Vontobel Holding’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-600,461
| Closed | -$1.8M | – | 1111 |
|
|
2023
Q3 | $1.8M | Buy |
600,461
+98,924
| +20% | +$297K | 0.02% | 449 |
|
|
2023
Q2 | $1.88M | Buy |
501,537
+120,687
| +32% | +$451K | 0.02% | 453 |
|
|
2023
Q1 | $1.28M | Buy |
380,850
+99,447
| +35% | +$333K | 0.01% | 523 |
|
|
2022
Q4 | $1.35M | Buy |
+281,403
| New | +$1.35M | 0.01% | 502 |
|
|
2021
Q4 | – | Sell |
-11,076
| Closed | -$388K | – | 1060 |
|
|
2021
Q3 | $388K | Sell |
11,076
-12,246
| -53% | -$429K | ﹤0.01% | 868 |
|
|
2021
Q2 | $501K | Buy |
+23,322
| New | +$501K | ﹤0.01% | 760 |
|